Using electronic health records to improve dementia screening in diverse communities
Official title: Leveraging Electronic Health Records for Reducing Dementia Screening Disparities in Diverse Communities
Funded at New York University School of Medicine · NIH-10932101 · Data updated 2026-11-12
This study is working to improve how we find Alzheimer's and related memory issues early, especially for people from different backgrounds who might not get the help they need, by using health records and teaming up with patients, families, and doctors to make sure everyone gets the right screenings and support.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 21, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $826,324 |
| NIH project number | 5R01AG079175-02 |
| Project ID | NIH-10932101 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals aged 65 and older, particularly those from socioeconomically disadvantaged backgrounds or racial and ethnic minority groups.
✕Less likely to help
Patients who are younger than 65 or those who do not have access to primary care services may not benefit from this research.
What this research studies
This research aims to enhance the early detection of Alzheimer's Disease and related dementias (AD/ADRD) by utilizing electronic health records (EHRs) to address disparities in cognitive screening among diverse populations. It focuses on socioeconomically disadvantaged and racial and ethnic minority groups who often face barriers to diagnosis and management of these conditions. The project will implement a pragmatic clinical trial that engages patients, families, and primary care providers to improve the quality of cognitive screening and secondary prevention efforts in primary care settings. By refining existing screening programs, the research seeks to ensure that more individuals receive timely evaluations and interventions.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and better management of dementia for underserved populations, ultimately improving patient outcomes.
How similar studies have gone: Previous research has shown that leveraging electronic health records can effectively improve screening and diagnosis in various health conditions, suggesting a promising approach for this initiative.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Razavian, Narges — New York University School of Medicine
- Study coordinator: Razavian, Narges
Related research
Other NIH-funded projects on the same topics.
-
Investigating how DNA damage and repair mechanisms are altered in ALS and frontotemporal dementia.
This study is looking at how problems with DNA repair might contribute to conditions like ALS and frontotemporal dementia, and it’s testing ways to fix these issues in cells from patients to help develop new treatments.
-
Synthetic protein mimetics to treat Lewy Body Dementia
A new therapeutic approach using engineered protein-like molecules to block the harmful protein clumps that cause Lewy Body Dementia.
-
Dementia care staff study: adapting a US survey for use in many countries
A study is adapting and testing a survey for dementia care workers in the US, Brazil, Switzerland, and Ghana to help understand why workers stay in their jobs and how to improve care.
-
Dementia care staff study: adapting a survey for use in many countries
A multinational study will adapt and test a U.S. dementia-care worker survey in Brazil, Switzerland, and Ghana to help understand why staff stay in or leave long-term care settings.
-
Study of Dementia Care Staff in 4 Countries: Adapting Caregiver Surveys Across Cultures
A multinational project will adapt and test a dementia care worker survey so researchers can compare care environments across the US, Brazil, Switzerland, and Ghana.
-
New biomarkers to distinguish LATE from Alzheimer’s disease in dementia
A study to develop blood and CSF tests that can tell apart LATE from Alzheimer’s disease in people with dementia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.